Compound Radar

Marex Group Limited (MRX) Stock Analysis

Price $76.71
Market cap $5.44B
Next earnings Nov 5, 2026
Entry status Wait $66.41–$70.51

Last updated Sep 8, 2026

Health Check

Last analyzed Sep 7, 2026

70
70/100 High Quality
  • Financial Health 50
  • Profitability 100
  • Business Quality 75
  • Balance Sheet 55
  • Cash Flow 78

Why this rating?

Health 70/100 — High Quality

Strongest Profitability 100/100
Softest Financial Health 50/100
Wait

Entry timing is weak right now. Quality may be fine; the setup is not.

Company overview

Marex Group Limited (MRX) is a Capital Markets company in the Financial Services sector. Compound Radar rates Marex Group Limited 70/100 (High Quality) due to high business quality, strong revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Strong
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 15.59
  • Forward P/E 12
  • EV/Revenue 1.97

Profitability

  • Revenue Growth 32.1%
  • Gross Margin 70.1%
  • Operating Margin 17.2%
  • Net Margin 12.2%
  • ROE 26.2%

Financial strength

  • Cash $14.21B
  • Debt $15.42B
  • Net Cash $-1.20B
  • Free Cash Flow $647.70M
  • Current Ratio 1.09

Similar companies

Peers in Capital Markets, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Capital Markets →

FAQ

How Compound Radar scores and tracks Marex Group Limited (MRX).

View Methodology & FAQ →